ONCO Scannersp. z o.o.
Research and experimental development in natural sciences and engineering
Overview
ONCO Scanner develops a probe for detecting cancerous tissue during breast cancer surgery by measuring differences in tissue electrical properties. In a study of 193 samples from 70 patients, the probe achieved 93% sensitivity and 87% specificity.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 17 days early.
- 202511/06/2026
- 202418/06/2025
- 202301/07/2024
- 202206/07/2023
- 202101/07/2022
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Oncological probe
- Tissue recognition device
- Intraoperative diagnostics
- Tumour localisation
- Clinical research
Website technology
- Website
- Nuxt
Authorized Representatives
Manner of representation
Both in the case of a one-person management board and in the case of a multi-member management board, each member of the management board independently represents the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Stanisław Bajage 70 | 370 | $4,997.30 | 25% |
Grzegorz Jajugaage 43 | 296 | $3,997.84 | 20% |
Kazimierz Władysław Orzechowskiage 69 | 370 | $4,997.30 | 25% |
Marek Krzysztof Rzącaage 69 | 370 | $4,997.30 | 25% |
Others | 74 | $999.46 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-07-14.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $133,705,101.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 13, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,432$1,432 | Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk | |
| Dec 21, 2020 | Aid for research and development projects: experimental development | $133.6M$133,607,263 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 21, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $86,559$86,559 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-05-01 | 816892 - Oncoscanner - oncoscanner oncological probe for intra-operative identification of cancerous tissues during surgical treatment for breast cancer | $58,968$58,968 | 1.1.31 - Horizon 2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Spectrace Echosp. z o.o. | $0.61 | spectrace.pl | ||
| Toptech R&Dsp. z o.o. | $0.21 | toptechpolska.pl | ||
| Inmed Clinicsp. z o.o. | $0.20 | inmed-clinic.pl |
FAQ
Last updated: 2026-06-11